Screener
Syndax Pharmaceuticals SNDX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-197154
FAQ
- What is Syndax Pharmaceuticals's price / sales?
- Syndax Pharmaceuticals (SNDX) reported price / sales of 9.5× in Q1 2026.
- How has Syndax Pharmaceuticals's price / sales changed year-over-year?
- Syndax Pharmaceuticals's price / sales decreased by 60.8% year-over-year, from 24.2× to 9.5×.
- What is the long-term trend for Syndax Pharmaceuticals's price / sales?
- Over 3 years (2020 to 2025), Syndax Pharmaceuticals's price / sales has grown at a -76.3% compound annual growth rate (CAGR), from 791.2× to 10.6×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Syndax Pharmaceuticals's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude